Why is Beryl Drugs falling/rising?

As of 24-Sep, Beryl Drugs Ltd is experiencing a price increase, with the current price at Rs 24.24, reflecting a rise of Rs 1.24 or 5.39%. The stock has shown strong performance today, outperforming its sector by 5.84% and achieving a consecutive gain over the last two days, resulting in an overall return of 8.17% during this period. Despite a wide intraday trading range and high volatility, the stock's weighted average price indicates more volume traded closer to its low price. Additionally, the stock is trading at a discount compared to its peers' average historical valuations, which contributes to its attractive valuation despite a significant decline in profits over the past year.
In the broader market context, Beryl Drugs has outperformed the Sensex in the short term, with a 1-week return of +5.39% compared to the benchmark's -1.18%. However, the stock has underperformed over the longer term, with a year-to-date decline of -32.95% against the Sensex's +4.58%. This disparity highlights the stock's weak long-term fundamental strength, evidenced by a low average Return on Capital Employed (ROCE) and poor growth metrics. While the recent positive price movement may attract investor interest, the underlying financial challenges and historical performance suggest caution for long-term investors.